Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
    All Public Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Healthcare Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • Common Ground
    • Diagnosis: Debt
    • The Body Shops
    • Priced Out
    • Guns, Race, and Profit
    • Deadly Denials
    • Dead Zone
    • Opioid Settlement Tracking
    • Eleven Minutes
    • Broken Rehab
    All Special Reports
  • More Topics

    More Topics

    • Elections
    • Healthcare Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health
    All Topics

  • Medicare Advantage Billing Probe
  • School Vaccine Mandates
  • Weight Loss Drugs Coverage
  • Opioid Settlement Money
  • Abortion Pill Access

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Thursday, Dec 8 2022

Full Issue

Help Wanted: Recruitment Tops ARPA-H Director's Early Priorities

Renee Wegrzyn, director of the Advanced Research Projects Agency for Health, told Stat that hiring program managers ranks high on her list of steps needed to prove that the federal investment in the new agency will pay off.

Stat: ARPA-H’s New Director Wants To Go On A Hiring Spree 

President Biden’s new health agency with a sweeping mandate to cure some of the system’s biggest problems has one big message: Please apply. (Owermohle, 12/7)

FDA Chief Robert Califf responds to a scathing report —

Stat: FDA Chief Calls Agency’s Food Program ‘Under-Supported’

FDA Commissioner Robert Califf said the food side of the agency needs more attention Wednesday, the day after an agency-commissioned report recommended increasing the prominence of its food program. (Wilkerson, 12/7)

In updates from Capitol Hill —

The Hill: Lawmakers Face Closing Window To Pass Landmark Bipartisan Marijuana Bill 

Lawmakers are facing a rapidly closing window to get key marijuana legislation across the finish line in the lame-duck session. Despite fetching broad bipartisan support in the House and Senate, opposition from GOP leadership and a tightening timeline is chipping away at the bill’s chances of passage. (Folley and Evers-Hillstrom, 12/7)

Fierce Healthcare: Bill That Puts More Antibiotics On Market No Sure Thing

Bacteria resistant to antibiotics continue to be a problem that merits monitoring because the pathogens can possibly kick-start the next pandemic, but a bill before Congress promises to wheel new medicinal weapons into the contest. The Pioneering Antimicrobial Subscriptions to End Upsurging Resistance (PASTEUR) Act, if passed, would create a public-private effort to create new antibacterial medications by reassuring pharmaceutical companies that there’d be a market for their product. (Diamond, 12/7)

ABC News: House Poised To Pass Bill Protecting Same-Sex, Interracial Marriage

The House on Thursday is set to pass a bill to codify federal recognition of same-sex and interracial marriages, bringing the landmark legislation one step closer to landing on President Joe Biden's desk for his signature. (Peller, 12/8)

Can Congress prevent another mess like what happened at Theranos? —

Stat: Congress Has A Chance To Close The FDA’s Theranos Loophole

Theranos, and the company’s notoriously inaccurate blood tests, could potentially have been stopped earlier if Congress had acted to fix a regulatory loophole. Lawmakers are weighing now whether it’s better late than never. (Cohrs and Owermohle, 12/8)

CNN: Ramesh 'Sunny' Balwani Sentenced To Nearly 13 Years In Prison For Fraud 

Ramesh “Sunny” Balwani, the former chief operating officer of failed blood testing startup Theranos, was sentenced Wednesday to nearly 13 years in prison for fraud. It marks an end to the stunning downfall of a high-flying Silicon Valley company that resulted in the rare convictions of two tech executives. (Thorbecke, 12/7)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, July 14
  • Monday, July 13
  • Friday, July 10
  • Thursday, July 9
  • Wednesday, July 8
  • Tuesday, July 7
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF